The authors conclude that these results “call into question the generalisability of current leading guideline recommendations that CHA2DS2-VASc scores of 1 and 2 points should serve as the threshold for use of anticoagulant therapy, and in the face of continued variation in point score specific stroke rates, guideline recommendations should better reflect the uncertainty in defining the optimal threshold for use of anticoagulants for patients with AF”.